14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 26, 2024 Buy 210 Healy James Common Stock
Apr 26, 2024 Buy 169 Baynes Roy D. Common Stock
Apr 26, 2024 Buy 488 Marcus Gail Boxer Common Stock
Apr 26, 2024 Buy 488 Chapman Rowan E Common Stock
Apr 26, 2024 Buy 244 Rosenman Herm Common Stock
Apr 26, 2024 Buy 488 Rosenman Herm Common Stock
Apr 26, 2024 Buy 278 Botha Roelof Common Stock
Apr 26, 2024 Buy 488 Botha Roelof Common Stock
Apr 26, 2024 Sell 751 Brophy Michael Burkes Common Stock
Apr 25, 2024 Sell 500 Sheena Jonathan Common Stock
Apr 25, 2024 Sell 705 Brophy Michael Burkes Common Stock
Apr 24, 2024 Sell 937 Brophy Michael Burkes Common Stock
Apr 23, 2024 Sell 787 Rabinowitz Daniel Common Stock
Apr 23, 2024 Sell 531 Moshkevich Solomon Common Stock
Apr 23, 2024 Sell 522 Fesko John Common Stock
Apr 23, 2024 Sell 2 552 Chapman Steven Leonard Common Stock
Apr 23, 2024 Sell 1 523 Brophy Michael Burkes Common Stock
Apr 22, 2024 Buy 1 250 Brophy Michael Burkes Common Stock
Apr 22, 2024 Sell 1 250 Brophy Michael Burkes Restricted Stock Unit
Apr 21, 2024 Buy 143 Sheena Jonathan Common Stock
Apr 21, 2024 Sell 143 Sheena Jonathan Restricted Stock Unit
Apr 21, 2024 Buy 644 Rabinowitz Daniel Common Stock
Apr 21, 2024 Sell 644 Rabinowitz Daniel Restricted Stock Unit
Apr 21, 2024 Buy 1 775 Chapman Steven Leonard Common Stock
Apr 21, 2024 Sell 1 775 Chapman Steven Leonard Restricted Stock Unit
Apr 21, 2024 Buy 1 145 Brophy Michael Burkes Common Stock
Apr 21, 2024 Sell 1 145 Brophy Michael Burkes Restricted Stock Unit
Apr 20, 2024 Buy 190 Sheena Jonathan Common Stock
Apr 20, 2024 Sell 190 Sheena Jonathan Restricted Stock Unit
Apr 20, 2024 Buy 856 Rabinowitz Daniel Common Stock
Apr 20, 2024 Sell 856 Rabinowitz Daniel Restricted Stock Unit
Apr 20, 2024 Buy 3 386 Chapman Steven Leonard Common Stock
Apr 20, 2024 Sell 3 386 Chapman Steven Leonard Restricted Stock Unit
Apr 20, 2024 Buy 1 521 Brophy Michael Burkes Common Stock
Apr 20, 2024 Sell 1 521 Brophy Michael Burkes Restricted Stock Unit
Apr 16, 2024 Sell 26 511 Moshkevich Solomon Common Stock
Apr 16, 2024 Sell 53 489 Moshkevich Solomon Common Stock
Apr 15, 2024 Sell 4 305 Chapman Steven Leonard Common Stock
Apr 15, 2024 Sell 2 411 Chapman Steven Leonard Common Stock
Apr 15, 2024 Sell 100 Chapman Steven Leonard Common Stock
Apr 03, 2024 Sell 8 699 Sheena Jonathan Common Stock
Apr 03, 2024 Sell 10 138 Sheena Jonathan Common Stock
Apr 03, 2024 Sell 7 863 Sheena Jonathan Common Stock
Apr 02, 2024 Sell 1 378 Brophy Michael Burkes Common Stock
Mar 28, 2024 Sell 134 Sheena Jonathan Common Stock
Mar 28, 2024 Sell 313 Sheena Jonathan Common Stock
Mar 28, 2024 Sell 500 Sheena Jonathan Common Stock
Mar 28, 2024 Sell 743 Rabinowitz Daniel Common Stock
Mar 28, 2024 Sell 707 Moshkevich Solomon Common Stock
Mar 28, 2024 Sell 464 Fesko John Common Stock
Mar 28, 2024 Sell 2 662 Chapman Steven Leonard Common Stock
Mar 28, 2024 Sell 914 Brophy Michael Burkes Common Stock
Mar 27, 2024 Buy 447 Sheena Jonathan Common Stock
Mar 27, 2024 Sell 447 Sheena Jonathan Restricted Stock Unit
Mar 27, 2024 Buy 1 364 Rabinowitz Daniel Common Stock
Mar 27, 2024 Sell 1 364 Rabinowitz Daniel Restricted Stock Unit
Mar 27, 2024 Buy 5 184 Chapman Steven Leonard Common Stock
Mar 27, 2024 Sell 5 184 Chapman Steven Leonard Restricted Stock Unit
Mar 27, 2024 Buy 2 292 Brophy Michael Burkes Common Stock
Mar 27, 2024 Sell 2 292 Brophy Michael Burkes Restricted Stock Unit
Mar 15, 2024 Sell 10 265 Chapman Steven Leonard Common Stock
Mar 15, 2024 Sell 20 575 Chapman Steven Leonard Common Stock
Mar 15, 2024 Sell 20 070 Chapman Steven Leonard Common Stock
Mar 15, 2024 Buy 807 Botha Roelof Common Stock
Mar 15, 2024 Buy 687 Botha Roelof Common Stock
Mar 15, 2024 Buy 607 Botha Roelof Common Stock
Mar 15, 2024 Buy 793 Botha Roelof Common Stock
Mar 15, 2024 Buy 851 Botha Roelof Common Stock
Mar 15, 2024 Buy 884 Botha Roelof Common Stock
Mar 15, 2024 Buy 14 136 Botha Roelof Common Stock
Mar 15, 2024 Buy 735 Botha Roelof Common Stock
Mar 15, 2024 Buy 424 Botha Roelof Common Stock
Mar 15, 2024 Sell 424 Botha Roelof Stock Option (right to buy)
Mar 15, 2024 Sell 735 Botha Roelof Stock Option (right to buy)
Mar 15, 2024 Sell 14 136 Botha Roelof Stock Option (right to buy)
Mar 15, 2024 Sell 884 Botha Roelof Stock Option (right to buy)
Mar 15, 2024 Sell 851 Botha Roelof Stock Option (right to buy)
Mar 15, 2024 Sell 793 Botha Roelof Stock Option (right to buy)
Mar 15, 2024 Sell 607 Botha Roelof Stock Option (right to buy)
Mar 15, 2024 Sell 687 Botha Roelof Stock Option (right to buy)
Mar 15, 2024 Sell 807 Botha Roelof Stock Option (right to buy)
Mar 15, 2024 Buy 18 750 Chapman Steven Leonard Common Stock
Mar 15, 2024 Buy 27 655 Chapman Steven Leonard Common Stock
Mar 15, 2024 Sell 19 929 Chapman Steven Leonard Common Stock
Mar 15, 2024 Buy 21 865 Chapman Steven Leonard Common Stock
Mar 15, 2024 Sell 34 960 Chapman Steven Leonard Common Stock
Mar 15, 2024 Sell 28 334 Chapman Steven Leonard Common Stock
Mar 15, 2024 Sell 27 655 Chapman Steven Leonard Stock Option (right to buy)
Mar 15, 2024 Sell 21 865 Chapman Steven Leonard Stock Option (right to buy)
Mar 15, 2024 Sell 18 750 Chapman Steven Leonard Stock Option (right to buy)
Mar 07, 2024 Sell 110 854 Sheena Jonathan Common Stock
Mar 07, 2024 Buy 55 427 Sheena Jonathan Common Stock
Mar 06, 2024 Sell 3 184 Sheena Jonathan Common Stock
Mar 06, 2024 Sell 1 816 Sheena Jonathan Common Stock
Mar 05, 2024 Sell 1 028 Sheena Jonathan Common Stock
Mar 05, 2024 Sell 2 160 Rabinowitz Daniel Common Stock
Mar 05, 2024 Sell 9 326 Chapman Steven Leonard Common Stock
Mar 05, 2024 Sell 2 826 Brophy Michael Burkes Common Stock
Mar 05, 2024 Sell 18 Moshkevich Solomon Common Stock
Feb 29, 2024 Buy 3 206 Moshkevich Solomon Common Stock
INSIDER POWER
-49.410
Last 100 transactions
Buy: 169 877 | Sell: 503 875 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of -49.410.

In total, the insiders bought 169 877 and sold 503 875 NTRA shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Natera

Natera Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; a... NTRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT